Cargando…
Protection of FK506 against neuronal apoptosis and axonal injury following experimental diffuse axonal injury
Diffuse axonal injury (DAI) is the most common and significant pathological features of traumatic brain injury (TBI). However, there are still no effective drugs to combat the formation and progression of DAI in affected individuals. FK506, also known as tacrolimus, is an immunosuppressive drug, whi...
Autores principales: | Huang, Ting-Qin, Song, Jin-Ning, Zheng, Feng-Wei, Pang, Hong-Gang, Zhao, Yong-Lin, Gu, Hua, Zhao, Jun-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428482/ https://www.ncbi.nlm.nih.gov/pubmed/28339015 http://dx.doi.org/10.3892/mmr.2017.6350 |
Ejemplares similares
-
FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury
por: Lee, Bohm, et al.
Publicado: (2022) -
Curcumin mitigates axonal injury and neuronal cell apoptosis through the PERK/Nrf2 signaling pathway following diffuse axonal injury
por: Huang, Tingqin, et al.
Publicado: (2018) -
Inhibiting endogenous tissue plasminogen activator enhanced neuronal apoptosis and axonal injury after traumatic brain injury
por: Zhao, Jun-Jie, et al.
Publicado: (2019) -
Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020) -
Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011)